Inauguration Ceremony Marks Landmark Occasion for Regenerative Medicine in the Region
April 22, 2024 – Global Stem Cells Group (GSCG) and ReGen proudly announce the formal integration of Churchill Aesthetic Center into ReGen’s distinguished membership in Brussels, Belgium. The opening ceremony, graced by esteemed leaders in the field of regenerative medicine, signifies a momentous stride forward for healthcare in the region. Distinguished attendees included Dr. Salih Yildirim, Director of ReGen and President of the International Society for Stem Cell Application (ISSCA), Benito Novas, Director of Public Relations for ISSCA and founder of the Global Stem Cells Group, and Dr. Samy Joheir, President of the Churchill Aesthetic Center.
The opening ceremony not only commemorated the Churchill Aesthetic Center’s membership celebration but also featured an advanced hair transplant course for local and international physicians, presenting the latest advances in aesthetic and regenerative medicine, including cutting-edge Turkish techniques in hair transplantation along with stem cell applications, with the goal of raising the standards of care and treatment outcomes in the region.
Expressing his profound satisfaction, Dr. Salih Yildirim remarked, “Expanding our footprint to Brussels, Belgium, and upcoming clinics in Albania and Antalya, fills me with immense pride and purpose. It is a privilege to extend the transformative benefits of regenerative medicine to the people of Belgium.”
Benito Novas further emphasized, “Our mission extends beyond borders; it is to propel the global movement of Regenerative Medicine, enriching lives and advancing healthcare standards worldwide. Regenerative medicine is not merely a promise for the future; it is the cornerstone of contemporary healthcare.”
The newly established center poised as a pivotal training hub for ISSCA
The newly established center is poised to serve as a pivotal training hub for ISSCA, facilitating the dissemination of knowledge and expertise among healthcare professionals in the region, thereby fostering continuous advancements in the field of regenerative medicine.
Strategic partnership between Global Stem Cells Group and ReGen
The strategic partnership between Global Stem Cells Group and ReGen has led to remarkable growth, establishing pioneering clinics worldwide. This partnership reflects GSCG’s commitment to global accessibility, with ReGen providing clinics and expertise, while GSCG contributes invaluable resources and comprehensive training through ISSCA. Together, they aim to positively impact countless lives worldwide.
About Global Stem Cells Group
Global Stem Cells Group is a leading provider of regenerative medicine solutions, dedicated to advancing healthcare through innovative therapies. With a global presence and a multidisciplinary team of experts, the organization strives to harness the potential of stem cells and regenerative medicine to improve patient outcomes across various medical fields. Through its extensive network of clinics, research facilities, and training centers, Global Stem Cells Group is committed to pushing the boundaries of regenerative medicine and making a positive impact on global healthcare.
About ReGen
ReGen is a highly acclaimed Turkish company with clinics in Turkey and in several other locations around the world, renowned for its expertise in cutting-edge technologies related to regenerative care. Headquartered in Istanbul, ReGen has gained international recognition for its commitment to excellence and its groundbreaking advancements in regenerative medicine. By partnering with Global Stem Cells Group, ReGen aims to share its advanced techniques and expertise on a global scale, improving access to regenerative care and transforming lives worldwide.
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
